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Mission and Vision 
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◊ 
• Pharmacy & Drug Control department (PDCD) takes 
the role of highest drug authority in Qatar  
◊ 
• To protect public health and safety of individuals, through 
scrutinizing and emphasizing that all medications and other 
pharmaceutical preparations imported and circulated in the 
country conform to higher international standards in terms of 
Safety, Quality and Effectiveness 
◊ 
• Emphasizes the readiness of the country in case of 
any emergency by participating actively in securing 
emergency stock of medicines and vaccines 
General Role and Activities 
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◊ • Development of medication policy for state of Qatar 
◊ 
• Quality control of medications, pharmaceuticals and raw 
materials 
◊ 
• Ensuring the compliance of the provided products to patients 
with worldwide standards 
◊ 
• Ensuring the availability of essential medicines in affordable 
prices 
◊ 
• Issuing of importing and exporting license for controlled 
medications and pharmaceutical products 
◊ 
• Control import and release of medications and other 
pharmaceutical products at all points of entry 
◊ • Control of herbal products and folk medications 
Structure and Functional Units of 
PDCD 
Registration 
Section 
Quality Control 
Lab 
Release Section 
Inspection & 
Narcotics Section 
8 
Registration Process 
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Embargo Impact 
The political 
crisis had an 
impact on 
medication 
accessibility 
in Qatar 
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Embargo Impact Contd. 
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Embargo Impact Contd. 
Total Number of Active Ingredients  
(same strength, Dosage form) ~ 1006 
Risk Level Similarities Number of Items  
High None  267 
High ≤ 2 221 
Moderate 3 55 
Low 4 24 
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Embargo Impact Contd. 
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Action Plan Taken (Immediate) 
 Establishment of  Emergency Committee including all Managers 
 List all the affected products 
 Determination of alternatives for each product 
 Fast tracking assessment of files. 
 Market update through: 
 Regular reports from inspection section to determine the actual stocks in the market 
including private pharmacies. 
 Communicating with local agents to provide regular reports to ensure at least 6 months 
stocks from all essential medicines. 
 Communicating with multinational pharmaceutical companies to ensure alternative 
supply chain. 
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Action Plan (Strategic or Long-Term) 
 Encouraging local pharmaceutical manufacturing plant to play a 
remarkable  role in securing local market needs. 
 Achieve equilibrium in registered items by ensuring registration of 
appropriate number of generics from every active ingredient, as well as 
ensuring multiple sources. 
 Continuous communication with all stakeholders to ensure at least 6 
months stock of essential medicines. 
 Continuous updating of MOPH requirements and guidelines to cope with 
worldwide guidelines, which will have positive impact on registration and 
availability of any newly discovered  product in the Qatari market. 
 
 
 
 
16 
Summary & Conclusion 
 Good healthcare system should ensure coverage, continuity, accessibility, 
quality and accountability during crisis as it was normal situation. 
 
  An efficient actions & crisis management with quick solution for long 
term  strategic effect to avoid similar condition in future. 
 
 Encouraging and supporting local manufacturing plants to participate in 
ensuring medication security in the state of Qatar.  
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